NCT01223456终止不适用
A Descriptive Study of the Efficacy and Safety of ONGLYZA (Saxagliptin) Under Conditions of Actual Use in the Philippines
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- AstraZeneca
- 入组人数
- 542
- 试验地点
- 1
- 主要终点
- Adverse events observed during the treatment duration
研究概览
简要总结
This post marketing surveillance study aims to monitor the safety and efficacy of ONGLYZA under conditions of actual use in patients who are diagnosed with diabetes mellitus type 2 and are prescribed ONGLYZA by their physician.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of Type 2 Diabetes Mellitus
- •Prescribed Saxagliptin by patient's attending physician
排除标准
- •Known allergic or serious adverse reaction to Saxagliptin
- •Pregnant or breastfeeding patients
结局指标
主要结局
Adverse events observed during the treatment duration
时间窗: Upon enrollment and initiation of Saxagliptin up to 14 days post follow-up
Clinical Response determined by cure rate
时间窗: Up to three (3) months after initiation of treatment
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Korean Post-marketing Surveillance for Onglyza®Diabetes Mellitus, Type 2NCT01575483AstraZeneca3,433
招募中
不适用
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasNCT04750798Biosense Webster, Inc.8,000
已完成
不适用
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaHepatitis C VirusNCT02907996Gilead Sciences2,033
已完成
4 期
A Study of Tadalafil (LY450190) in Chinese Men With Erectile DysfunctionErectile DysfunctionNCT02224846Eli Lilly and Company635
已完成
不适用
An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With HypertensionHypertensionNCT00904215Boehringer Ingelheim1,095